Chilean Scientists' Hantavirus Antibody Breakthrough Stalled by Funding Issues
Andes Hantavirus Treatment Shows Promise in Lab and Animal Studies but Awaits Human Trials
L'essentiel
Chilean researchers developed antibodies neutralizing the deadly Andes hantavirus in lab and animal studies, but lack of funding and the Covid-19 pandemic halted progress toward human trials, despite recent outbreaks highlighting the need for a treatment.
Résumé généré par IA
Chilean researchers developed antibodies neutralizing the deadly Andes hantavirus in lab and animal studies, but lack of funding and the Covid-19 pandemic halted progress toward human trials, despite recent outbreaks highlighting the need for a treatment.
